Miguel Martín Selected Research

Miguel Martín Research Topics

Disease

92	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2003
50	Neoplasms (Cancer) 04/2024 - 01/2007
8	Neoplasm Metastasis (Metastasis) 04/2022 - 06/2008
6	Disease Progression 03/2024 - 10/2005
6	Pathologic Complete Response 03/2024 - 06/2015
6	Triple Negative Breast Neoplasms 03/2024 - 05/2018
6	Cardiotoxicity 01/2023 - 01/2009
2	Residual Neoplasm 01/2022 - 11/2017
2	Fatigue 10/2021 - 07/2010
2	Hand-Foot Syndrome 01/2021 - 05/2014
2	Melanoma (Melanoma, Malignant) 10/2020 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 02/2011
2	Neutropenia 01/2018 - 03/2007
2	Colorectal Neoplasms (Colorectal Cancer) 03/2016 - 05/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2016
2	Circulating Neoplastic Cells 01/2013 - 11/2006
2	Febrile Neutropenia 03/2007 - 07/2004
1	Hypothyroidism 02/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2023
1	Cross Infection (Nosocomial Infection) 09/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Nausea 10/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 08/2021
1	Cholangiocarcinoma 06/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2020
1	Necrosis 10/2020

Drug/Important Bio-Agent (IBA)

26	Hormones (Hormone)IBA 10/2023 - 01/2007
18	AnthracyclinesIBA 03/2024 - 02/2003
13	Docetaxel (Taxotere)FDA Link 06/2021 - 07/2004
12	Trastuzumab (Herceptin)FDA Link 04/2024 - 10/2005
11	Capecitabine (Xeloda)FDA Link 01/2023 - 06/2005
9	Taxoids (Taxanes)IBA 09/2021 - 02/2003
8	human ERBB2 proteinIBA 02/2024 - 01/2013
8	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2019 - 06/2008
6	Estrogen ReceptorsIBA 03/2024 - 10/2012
6	Phenobarbital (Luminal)FDA Link 09/2023 - 10/2012
5	Fulvestrant (Faslodex)FDA Link 03/2024 - 03/2015
5	Aromatase InhibitorsIBA 03/2024 - 01/2012
5	ribociclibIBA 01/2023 - 01/2018
5	130-nm albumin-bound paclitaxelIBA 06/2019 - 06/2013
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2015 - 06/2008
4	taxaneIBA 04/2024 - 01/2016
4	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2016
4	thiamine triphosphorate (TTP)IBA 04/2022 - 10/2005
4	PlatinumIBA 01/2020 - 02/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013 - 07/2004
3	Circulating Tumor DNAIBA 10/2023 - 12/2019
3	palbociclibIBA 01/2023 - 10/2021
3	Letrozole (Femara)FDA LinkGeneric 05/2022 - 03/2015
3	Carboplatin (JM8)FDA LinkGeneric 12/2018 - 01/2017
3	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2012
3	Denosumab FDA Link 01/2016 - 10/2013
3	Epirubicin (Ellence)FDA LinkGeneric 11/2015 - 06/2008
3	Fluorouracil (Carac)FDA LinkGeneric 07/2013 - 06/2008
2	trastuzumab deruxtecanIBA 04/2024 - 02/2024
2	AntibodiesIBA 02/2024 - 01/2019
2	Tamoxifen FDA LinkGeneric 10/2023 - 01/2013
2	abemaciclibIBA 10/2023 - 09/2023
2	Genetic Markers (Genetic Marker)IBA 01/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 01/2023 - 10/2016
2	pertuzumabIBA 01/2023 - 06/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022 - 02/2020
2	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 04/2011
2	liposomal doxorubicin (Doxil)FDA Link 09/2021 - 07/2010
2	neratinibIBA 06/2020 - 06/2012
2	Anastrozole (Arimidex)FDA LinkGeneric 08/2019 - 01/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2018 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 11/2017 - 01/2013
2	Albumin-Bound Paclitaxel FDA Link 11/2017 - 06/2013
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2007 - 02/2003
1	giredestrantIBA 03/2024
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2024
1	Formaldehyde (Formol)FDA Link 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	ParaffinIBA 01/2023
1	SolutionsIBA 12/2022
1	sacituzumab govitecanIBA 12/2022
1	Codon (Codons)IBA 01/2022
1	spartalizumabIBA 01/2022
1	Olive OilIBA 01/2022
1	BO-112IBA 10/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2020
1	NivolumabIBA 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	Poly I-CIBA 10/2020
1	pembrolizumabIBA 10/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2020

Therapy/Procedure

54	Therapeutics 03/2024 - 06/2005
39	Drug Therapy (Chemotherapy) 03/2024 - 02/2003
9	Neoadjuvant Therapy 04/2024 - 08/2009
8	Adjuvant Chemotherapy 01/2020 - 01/2007
3	Precision Medicine 05/2019 - 11/2017
3	Radiotherapy 09/2015 - 01/2012
2	Intravenous Infusions 01/2020 - 10/2016
2	Induction Chemotherapy 07/2011 - 07/2010
1	Lymph Node Excision (Lymph Node Dissection) 02/2023
1	Hand Hygiene 09/2022
1	Drug Tapering 01/2021